To investigate the mechanisms by which FZD6 knockdown impairs the growth and DNA damage repair of prostate cancer cells, we performed a reverse-phase protein array (RPPA) with 466 antibodies to identify differentially expressed proteins between the DU145 cells expressing the FZD6 shRNAs and control scrambled shRNA. This evidence concerns the gene FZD6 and prostate cancer.